SBIR/STTR Research Award

Targeted Imaging of Fibrosis in the Left Atrium

Award identifier 0a639192af994b0e0d725086d6e7a88f49a1904b1bb3b39a413e99c901738d5bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$295,301

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
COLLAGEN MEDICAL LLC
Proposal award date
2018-08-15
Contract end date
2019-07-31
UEI
GJLBDQT8K757
Solicitation number
PA17-302
Topic code
NIA

Research abstract

Abstract SignificanceAtrial fibrosis plays a central role in the development of atrial fibrillationAFand heart failurewhich are both common conditions in the elderly and associated with significant morbidity and mortalityThis proposal addresses an unmet diagnostic need for non invasive methods to characterize atrial fibrosis through non invasive molecular imaging of typecollagenthe hallmark pathology of atrial fibrosisHypothesisWe hypothesize that a collagen binding gadolinium chelate will localize in fibrotic atrial tissuethus enabling targeted molecular imaging of atrial fibrosis to be performed with a high degree of accuracyPreliminary dataThe affinity and specificity of Collagen Medical s proprietary probe CMfor typecollagen are well establishedOur preliminary efficacy data have established that CMcan quantify fibrosis burden in a rat bile duct ligation modelBDLof chronic liver diseaseAdditionallyCMenhanced differences in Tand signal intensity in a canine myocardial infarct model were shown to be related to the fibrosis burden in the left ventricleHerefor the first timewe propose to use the agent to image left atrial fibrosis using a porcine model of atrial fibrillationSpecific AimsIn PhaseSpecific Aimof this Fast Track proposal we aim to establish that CMspecifically accumulates in regions of atrial fibrosis as compared with a non targeted control and that it can be imaged in vivo with Tweighted sequencesA porcine model of focal left atrial fibrosis created using radiofrequency ablation catheters will be usedThe gating decision criteria for a transition to Phaseare based on quantitative assessment of tissue specificity vsnon targeted control and in vivo imagingIn PhaseSpecific Aimof the grantwe will demonstrate the ability of CMenhanced MRI to quantify patchy and diffuse left atrial fibrosis in a porcine model of atrial fibrillation and will compare the collagen targeted agent to the current gold standardlate gadolinium enhancementLGEusing the non targeted agentGd DOTAOverall ImpactWe anticipate that the targeted and specific nature of CMwill produce significantly more accurate data than LGE using non targeted chelatesthe current gold standardTogetherdata obtained in these studies will support an IND application and accelerate translation into the clinical realm Project Narrative Non invasive characterization of left atrial fibrosis is a significant unmet diagnostic need for elderly patientswho frequently suffer from atrial fibrillation and heart failureThis project employs a new collagen targeted magnetic resonance probe to specifically image left atrial fibrosis in a large animal model of atrial fibrillation

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

20 SBIR/STTR records share this UEI (2012–2024). Reported award amounts total $15,782,674. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.